- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence-Based Practice: Temozolomide Beyond Glioblastoma
Authors
Keywords
Temozolomide, Low grade glioma, GBM in the elderly, Ependymoma, Pilocytic astrocytoma, Pleomorphic xanthoastrocytoma, DIPG, Bevacizumab
Journal
Current Oncology Reports
Volume 21, Issue 4, Pages -
Publisher
Springer Nature
Online
2019-03-05
DOI
10.1007/s11912-019-0783-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Grade II and III Oligodendroglioma and Astrocytoma
- (2018) Martin J. van den Bent et al. NEUROLOGIC CLINICS
- Bispecific antibodies for cancer therapy: A review
- (2018) Anuradha Krishnamurthy et al. PHARMACOLOGY & THERAPEUTICS
- Adult Pilocytic Astrocytoma: An Institutional Series and Systematic Literature Review for Extent of Resection and Recurrence
- (2018) Kamila M. Bond et al. World Neurosurgery
- Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
- (2018) Erica H. Bell et al. JAMA Oncology
- The application of CAR-T cell therapy in hematological malignancies: Advantages and challenges
- (2018) Zijun Zhao et al. Acta Pharmaceutica Sinica B
- Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
- (2018) Katherine Elizabeth Warren Frontiers in Oncology
- Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status
- (2018) Eric M. Thompson et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
- (2018) Barbara Fisher et al. NEURO-ONCOLOGY
- Diffuse Infiltrating Oligodendroglioma and Astrocytoma
- (2017) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
- (2017) Sophie E. M. Veldhuijzen van Zanten et al. JOURNAL OF NEURO-ONCOLOGY
- Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis
- (2017) Hadeel Hassan et al. JOURNAL OF NEURO-ONCOLOGY
- Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics
- (2017) C. Izquierdo et al. JOURNAL OF NEURO-ONCOLOGY
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma
- (2017) Patrick Flannery et al. ONCOLOGY REPORTS
- Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen
- (2017) Clemens Seidel et al. STRAHLENTHERAPIE UND ONKOLOGIE
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Chemotherapy for intracranial ependymoma in adults
- (2016) Dorothee Gramatzki et al. BMC CANCER
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
- (2016) Brigitta G Baumert et al. LANCET ONCOLOGY
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
- (2016) Jan C. Buckner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pleomorphic Xanthoastrocytoma with Anaplastic Features in the Tectal Region in a Young Adult Patient: A Case Report
- (2016) Yuuto Suzuki et al. World Neurosurgery
- Pilocytic astrocytoma: pathology, molecular mechanisms and markers
- (2015) V. Peter Collins et al. ACTA NEUROPATHOLOGICA
- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
- (2015) Barbara J. Fisher et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adult brainstem gliomas: Correlation of clinical and molecular features
- (2015) Brett J. Theeler et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study
- (2015) Roberta Rudà et al. NEURO-ONCOLOGY
- Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
- (2014) Daniela Rizzo et al. JOURNAL OF CHEMOTHERAPY
- Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
- (2014) Rintaro Hashizume et al. NATURE MEDICINE
- Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma
- (2014) S. J. Han et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- A case of pleomorphic xanthoastrocytoma with anaplastic features in the pineal gland
- (2013) Kosuke Katayama et al. Brain Tumor Pathology
- Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04)
- (2013) S. Bailey et al. EUROPEAN JOURNAL OF CANCER
- Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients
- (2013) Ranjith Babu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Molecular analysis of diffuse intrinsic brainstem gliomas in adults
- (2013) German Reyes-Botero et al. JOURNAL OF NEURO-ONCOLOGY
- Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
- (2013) A. D. Norden et al. NEURO-ONCOLOGY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
- (2012) Antonio Omuro et al. NEURO-ONCOLOGY
- Adult Brainstem Gliomas
- (2012) G. Reyes-Botero et al. ONCOLOGIST
- Bevacizumab and daily temozolomide for recurrent glioblastoma
- (2011) Annick Desjardins et al. CANCER
- Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
- (2011) Jaime Gállego Pérez-Larraya et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
- (2011) D.-S. Kong et al. NEURO-ONCOLOGY
- Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
- (2011) K. J. Cohen et al. NEURO-ONCOLOGY
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
- (2010) Ufuk Abacioglu et al. JOURNAL OF NEURO-ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience
- (2008) Maura Massimino et al. JOURNAL OF NEURO-ONCOLOGY
- Natural history and management of brainstem gliomas in adults
- (2008) A. Salmaggi et al. JOURNAL OF NEUROLOGY
- Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma
- (2008) Nongnuch Sirachainan et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now